Constitutional Oncogenetics. Noureddine Boukhatem
9 Familial Malignant Melanoma 9.1. Introduction 9.2. Prevalence 9.3. When to suspect familial malignant melanoma 9.4. Tumors 9.5. Genes 9.6. Genotype–phenotype correlations 9.7. Penetrance 9.8. Mode of transmission 9.9. Monitoring 10 Gorlin Syndrome 10.1. Introduction 10.2. Prevalence 10.3. When to suspect GS 10.4. Tumors 10.5. Genes 10.6. Genotype–phenotype correlations 10.7. Penetrance 10.8. Mode of transmission 10.9. Monitoring
7
PART 2: Infracentesimal Syndromes
11 Li—Fraumeni Syndrome
11.1. Introduction
11.2. Gene
11.3. Tumors
11.4. Genetics
11.5. Monitoring
12 Ataxia–telangiectasia
12.1. Introduction
12.2. Gene
12.3. Tumors
12.4 Genetics
12.5. Monitoring
13 Hyperparathyroidism
13.1. Introduction
13.2. Gene
13.3. Tumors
13.4. Genetics
13.5. Monitoring
14 Hamartomatous Polyposis Syndromes
14.1. PTEN-hamartoma tumor syndromes
14.2. Juvenile polyposis syndrome
14.3. Peutz–Jeghers syndrome
15 Fanconi Syndrome
15.1. Introduction
15.2. Gene
15.3. Tumors
15.4. Genetics
15.5. Monitoring
16 Hereditary Diffuse Gastric Cancer
16.1. Introduction
16.2. Gene
16.3. Tumors
16.4. Genetics
16.5. Monitoring
17 Von Hippel–Lindau Disease
17.1. Introduction
17.2. Gene
17.3. Tumors
17.4. Genetics
17.5. Monitoring
18 Xeroderma Pigmentosum
18.1. Introduction
18.2. Gene
18.3. Tumors
18.4. Genetics
18.5. Monitoring
19 Hereditary Papillary Renal Carcinoma
19.1. Introduction
19.2. Gene
19.3. Tumors
19.4. Genetics
19.5. Monitoring
20 Retinoblastoma
20.1. Introduction
20.2. Gene
20.3. Tumors
20.4. Genetics
20.5. Monitoring
21 Carney Complex
21.1. Introduction
21.2. Gene
21.3. Tumors
21.4. Genetics
21.5. Monitoring
22 Hematological Malignancies
22.1. Introduction
22.2. Gene
22.3. Tumors
22.4. Genetics
22.5. Monitoring
23 Familial Pituitary Adenomas
23.1. Introduction
23.2. Gene
23.3. Tumors
23.4.